Duran-Salgado M B,Rubio-Guerra A F. Diabetic nephropathy and inflammation[J]. World J Diabetes, 2014(3): 393.
[2]
Huang Y L, Cai X Y, Zhang J Y, et,al. Prehypertension and incidence of ESRD: a systematic review and meta-analysis[J]. Am J Kidney Dis, 2014, 63(1): 76.
[3]
Wang Y, Chen J Y, Wang Y E. A meta-analysis of the clinical remission rate and long-term efficacy of tonsillectomy in patients with IgA nephropathy[J]. Nephrol Dial Transplant, 2011(26): 1923.
[4]
Jan O Friedrich, Neill K J Adhikari, Joseph Beyene.Inclusion of zero total event trials in meta-analyses maintains analytic consistency and incorporates all available data[J]. BMC Med Res Methodol, 2007(7): 5.
Sanchez A P, Sharma K. Transcription factors in the pathogenesis of diabetic nephropathy[J]. Expert Rev Mol Med, 2009, 11: e13.
[23]
Lampropoulou I T,Stangou M,Papagianni A,et al. TNF-ɑ and microalbuminuria in patients with type 2 diabetes mellitus[J]. J Diabetes Res,2014(2014):394206.
[24]
Lei L, Mao Y, Meng D, et al.Percentage of circulating CD8+ T lymphocytes is associated with albuminuria in type 2 diabetes mellitus[J]. Exp Clin Endocrinol Diabetes, 2014, 122: 27.
[25]
Zhao J Y, Dong J J, Wang H P,et al. Efficacy and safety of vitamin D3 in patients with diabetic nephropathy: a meta-analysis of randomized controlled trials[J]. Chin Med J, 2014,127(15):122.
[26]
Montserrat B, Duran-Salgado, Alberto F, et al. Rubio-Guerra diabetic nephropathy and inflammation[J]. World J Diabetes, 2014, 5(3): 393.
[27]
Su J, Li S J, Chen Z H, et al. Evaluation of podocyte lesion in patients with diabetic nephropathy: Wilms\' tumor-1 protein used as a podocyte marker[J]. Diabetes Res Clin Pract, 2010, 87(2): 167.
[28]
Zhu W W, Chen H P, Ge YC, et al. Ultrastructural changes in the glomerular filtration barrier and occurrence of proteinuria in Chinese patients with type 2 diabetic nephropathy[J]. Diabetes Res Clin Pract, 2009, 86: 199.
[29]
Wu Y, Cui J, Bao X,et al. Triptolide attenuate oxidative stress, NF-kB activation and multiple cytokine gene expression in murine peritoneal macrophage[J]. Int J Mol Med, 2006, 17: 141.
[30]
Fornoni A, Ijaz A, Tejada T, et al.Role of inflammation in diabetic nephropathy[J]. Curr Diabetes Rev, 2008, 4(1): 10.
Schulz K F, Altman D G, Moher D. Consort 2010 statement: updated guidelines for reporting parallel group randomised trials[J]. J Pharmacol Pharmacother, 2010, 1(2): 100.
